Patents by Inventor Paul James Davis

Paul James Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100183701
    Abstract: A skin dressing comprises a hydrated hydrogel material including a source of lactate ions and a supply of glucose, optionally also including a source of zinc ions and a source of iodide ions. The dressing has beneficial effects on skin.
    Type: Application
    Filed: March 30, 2010
    Publication date: July 22, 2010
    Inventors: Paul James Davis, Andrew John Austin, Jan Jezek
  • Patent number: 7731954
    Abstract: A skin dressing, particularly a wound dressing, comprises oxidoreductase enzyme and, optionally, peroxidase enzyme, wherein the enzyme(s) are present in hydrated condition, e.g. being present in one or more hydrated hydrogels. The dressing is used by being located on the skin of a human or animal e.g. over a wound. The oxidoreductase enzyme catalyses a reaction that produces hydrogen peroxide from an appropriate substrate, the substrate either being naturally present in body fluids and/or being supplied separately and/or being incorporated into the dressing. The currently preferred oxidoreductase enzyme is glucose oxidase. The catalyses reaction of ?-D-glucose substrate to give hydrogen peroxide and gluconic acid. A mixture of oxidoreductase enzyme can undergo reaction (optionally catalysed by the peroxidase enzyme) to produce a variety of species including reactive oxygen intermediates that have antimicrobial properties and that can therefore assist in promoting wound healing.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: June 8, 2010
    Assignee: Insense Limited
    Inventors: Paul James Davis, Andrew John Austin
  • Patent number: 7629178
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilized in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reacts on in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: December 8, 2009
    Assignee: Inverness Medical Switzerland GmbH
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Publication number: 20090203059
    Abstract: A protease detection product (1) for detecting a protease enzyme in a sample. The protease detection product (1) comprises a medium (2) providing a liquid flow path; a labelled component (6) located on the liquid flow path; a capture component (12) located downstream of the labelled component (6) and immobilisation means (8) for immobilising the intact labelled component. The labelled component (7) comprises a base element (8) connected to releasable element via a protease-sensitive linker peptide (9). The releasable element comprises a label (10). The capture component (12) is capable of binding the releasable element.
    Type: Application
    Filed: April 5, 2007
    Publication date: August 13, 2009
    Applicant: Mologic Ltd.
    Inventors: Mark James Davis, Paul James Davis, Mark Burnapp
  • Publication number: 20090191582
    Abstract: An enzyme detection product (1) for detecting the presence of an enzyme in a sample. The product (1) comprises: a reaction zone (16) for receiving the sample; a visualization zone (10) for presenting a signal in response to the detection of the activity of the enzyme; and a membrane (11). The membrane (11) is interposable between the reaction zone (16) and the visualization zone (10) and prevents passage from the reaction zone (16) to the visualization zone (10) the components having a size greater than a threshold size. The reaction zone (16) comprises a reactant capable of reacting with the enzyme in order to generate a reaction product having a size less than a threshold size.
    Type: Application
    Filed: February 23, 2007
    Publication date: July 30, 2009
    Applicant: Mologic Ltd
    Inventors: Paul James Davis, Mark James Davis, Mark Burnapp, Sandra Hemmington
  • Publication number: 20090169600
    Abstract: A delivery system, e.g. a skin dressing, comprising an upper component, comprising hydrogen peroxide, and a lower component in hydrated condition, such that when the upper and lower components are placed in contact with each other, hydrogen peroxide migrates towards the lower component is provided.
    Type: Application
    Filed: July 18, 2007
    Publication date: July 2, 2009
    Inventors: Paul James Davis, Andrew John Austin
  • Publication number: 20090098020
    Abstract: A binding assay product (1) for detecting the presence of an analyte in a sample comprising a labelling module (5), a label, a capture module (9) and a visualisation module (10). The labelling module (5) comprises a first binding component capable of binding the analyte. The label is connectable to the first binding component. The capture module (9) comprises a second binding component capable of binding the analyte. The visualisation module (10) is for detecting the first binding component connected to the label and bound to the second binding component via the analyte. The labelling module and the capture module comprise a fluid conducting medium in which the binding components are embedded. The labelling module (5), the capture module (9) and the visualisation module (10) together define a flow path along which the sample is capable of flowing.
    Type: Application
    Filed: February 23, 2007
    Publication date: April 16, 2009
    Applicant: Mologic Ltd
    Inventors: Paul James Davis, Mark James Davis, Mark Burnapp, Julie Thompson
  • Publication number: 20090053738
    Abstract: A method of detecting a protease in a sample. The method comprises providing an analyte degradable by the protease. The analyte is contacted with the sample. The degradation products of the analyte or the residual undegraded analyte is detected in a binding assay.
    Type: Application
    Filed: February 23, 2007
    Publication date: February 26, 2009
    Applicant: Mologic Ltd.
    Inventors: Paul James Davis, Mark James Davis, Mark Burnapp
  • Publication number: 20090036350
    Abstract: A method of sterilising a protein in an aqueous environment, comprises exposing to ionising radiation an aqueous composition comprising the protein with a protective compound or combination of protective compounds having the following characteristics: (i) a rate of reaction with hydroxyl radicals greater than 5×108 L mol?1 s?1; and (ii) a non-polar region.
    Type: Application
    Filed: September 21, 2006
    Publication date: February 5, 2009
    Inventors: Andrew John Austin, Jan Jezek, Paul James Davis, Roy Thomas Dobb, Lynne Patricia Watson, John Patrick Gordon Wilkins
  • Patent number: 7407813
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilised in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reaction in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: August 5, 2008
    Assignee: Inverness Medical Switzerland GmbH
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Patent number: 7384796
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilised in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reaction in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: June 10, 2008
    Assignee: Inverness Medical Switzerland GmbH
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Publication number: 20080131317
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilised in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reacts on in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Application
    Filed: October 25, 2007
    Publication date: June 5, 2008
    Applicant: Inverness Medical Switzerland GmbH
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Patent number: 7237504
    Abstract: Apparatus for detecting a specific target odour comprises: a detector unit adapted to have removably associated therewith a holding unit for housing at least one insect in a predetermined position; means for exposing an insect in a holding unit associated with the detector unit to a sample of gas to be tested; and means for enabling monitoring of a response of the insect to the sample thereby to detect a response indicative of the target odour. In use of the apparatus, a holding unit housing at lest one insect that responds in a detectable manner to the target odour is associated with the detector unit. A sample of gas to be tested is supplied to the apparatus, for exposure to the insect or insects in the holding unit. The insect is monitored for a response indicative of the target odour, thus enabling determination as to whether or not the target odour is present in the sample.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: July 3, 2007
    Assignee: Inscentinel Limited
    Inventors: Paul James Davis, Lester Wadhams, Justin Sheldon Bayliss
  • Patent number: 7238537
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilized in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reaction in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: July 3, 2007
    Assignee: Inverness Medical Switzerland GmbH
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Patent number: 7041793
    Abstract: Detergent composition comprising fusion protein comprising a cellulose binding domain and a domain having a high binding affinity for another ligand. Preferably, the domain having a high binding affinity is directed at a Benefit Agent.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: May 9, 2006
    Assignee: Unilever Home & Personal Care USA Division of Conopco, Inc.
    Inventors: Paul James Davis, Neil James Parry
  • Patent number: 7036454
    Abstract: An insect holder for holding an insect, e.g. a forager honey bee, comprises a housing with a chamber adapted to receive the insect, an inlet to the chamber through which the insect can pass to enter the chamber, and a head opening to the chamber adapted to permit the head of the insect in the chamber to pass therethrough to the exterior of the housing while retaining the insect in the housing, with the head of the insect protruding through the head opening to the exterior of the housing. The insect is constrained to be unable to turn around in the chamber or withdraw its head into the chamber, so that observations can be made on the insect head, e.g. monitoring proboscis movement in known manner. When observations are finished, the insect is released unharmed and undamaged.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: May 2, 2006
    Assignee: Inscentinal Limited
    Inventors: Paul James Davis, Peter William Tomkins, Kenneth Alan Cherry, Justin Sheldon Bayliss
  • Patent number: 6919428
    Abstract: Fusion protein comprising a cellulose binding domain and a domain having a high binding affinity for another ligand and detergent compositions comprising such fusion proteins.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: July 19, 2005
    Assignee: Unilever Home Products and Care USA division of Conopco, Inc.
    Inventors: Paul James Davis, Neil James Parry
  • Publication number: 20030219908
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilised in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reaction in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Application
    Filed: December 23, 2002
    Publication date: November 27, 2003
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Publication number: 20030207465
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilised in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reaction in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Application
    Filed: September 4, 2001
    Publication date: November 6, 2003
    Applicant: Unilever Patent Holdings B.V
    Inventors: Paul James Davis, Michael Evans Prior, Keith May
  • Publication number: 20030143755
    Abstract: An analytical test device incorporating a dry porous carrier to which a liquid sample, eg. urine, suspected of containing an analyte such as HCG or LH can be applied indirectly, the device also incorporating a labelled specific binding reagent which is freely mobile in the porous carrier when in the moist state, and an unlabelled specific binding reagent which is permanently immobilised in a detection zone on the carrier material, the labelled and unlabelled specific binding reagents being capable of participating in either a sandwich reaction or a competition reaction in the presence of the analyte, in which prior to the application to the device of a liquid sample suspected of containing the analyte, the labelled specific binding reagent is retained in the dry state in a macroporous body, eg.
    Type: Application
    Filed: December 23, 2002
    Publication date: July 31, 2003
    Inventors: Paul James Davis, Michael Evans Prior, Keith May